1461117959-db3e5869-4252-4ed5-a402-583c8b6e3033

1. A method for increasing the contained volume and the rate of outgassing of volatile corrosion inhibitor in a plastic bag comprising:
extruding the plastic bag in a continuous extrusion process from raw material having therein volatile corrosion inhibitor with a series of spaced apart parallel longitudinal ribs on the inside of the bag such that the total volume and total surface area of the inside of the bag is greater than it would be without ribs thereby increasing the contained volume and rate of outgassing into the bag interior of volatile corrosion inhibitor contained in the plastic;
forming in said extrusion process a layflat bag having two adjacent flat sides and heat sealing across the two adjacent sides to define a closed bottom end of the bag and separating said bags proximate the heat seal to define an open top end of the bag.
2. The method of claim 1 further wherein said ribs are spaced apart from about 0.200 inch to about 0.750 inch.
3. The method of claim 2 further wherein said ribs have a height from about 0.020 inch to about 0.060 inch.
4. The method of claim 1 wherein the ratio of the distance the ribs are spaced apart to their height is from about 3:1 to 10:1.
5. The method of claim 1 wherein the ratio of the rib width to the rib height is from about 3:1 to 1:1.
6. The method of claim 1 further wherein said ribs are generally rounded in shape.
7-17. Cancelled
18. A method of increasing the contained volume and the rate of outgassing of volatile corrosion inhibitor in a plastic bag comprising:
providing an extrusion die having recess elements to form a series of spaced apart longitudinal ribs in the interior of plastic bags formed by such die;
extruding plastic bags from said die in a continuous extrusion process from raw materials having therein volatile corrosion inhibitor said plastic bags formed by said die having a series of spaced apart longitudinal ribs in the interior of the plastic bags formed by such die such that the total volume and total surface area of the inside of the bag is greater than it would be without ribs;
forming in said extrusion process a layflat bag having two adjacent flat sides and heat sealing across the two adjacent sides to define a closed bottom end of the bag and separating said bags proximate the heat seal to define an open top end of the bag;
whereby the longitudinal ribs provide increased volume to increase the contained volume of volatile corrosion inhibitor in the bag and the longitudinal ribs provide increased surface area in the bag interior thereby increasing the rate of outgassing into the bag interior of the volatile corrosion inhibitor contained therein.
19. A method of protecting electronic devices stored in a plastic bag comprising;
extruding the plastic bag in a continuous extrusion process from raw material having therein volatile corrosion inhibitor with a series of spaced apart parallel longitudinal ribs on the inside of the bag such that the total volume and total surface area of the inside of the bag is greater than it would be without ribs thereby increasing the contained volume and rate of outgassing into the bag interior of volatile corrosion inhibitor contained in the plastic;
forming in said extrusion process a layflat bag having two adjacent flat sides and heat sealing across the two adjacent sides to define a closed bottom end of the bag and separating said bags proximate the heat seal to define an open top end of the bag; and
inserting an electronic device inside the plastic bag.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A vacuum deposition source comprising:
a base flange configured to mount the vacuum deposition source to a vacuum chamber, the base flange comprising an electrical power feed-through;
a crucible operatively supported relative to the base flange and configured to hold vacuum deposition material, the crucible comprising a body portion and an effusion orifice;
a heater operatively supported relative to the base flange and at least partially surrounding the crucible, the heater comprising a cylindrically curving electrical contact surface; and
an electrical contact assembly comprising a power strap electrically connected to the electrical power feed-through at a first end of the power strap, electrically connected to the electrical contact surface of the heater at a second end of the power strap, and comprising a conductive washer in contact with the cylindrically curving electrical contact surface, the power strap positioned between a contact washer and the conductive washer, a pressure pin in contact with the contact washer, a first surface of a pyrolytic boron nitride spring in contact with the pressure pin, and at least one loading pin in contact with a second surface of the pyrolytic boron nitride spring thereby providing a compressive load on the conductive washer.
2. The vacuum deposition source of claim 1, wherein the power strap comprises one or more of a flat electrical contact surface and an arcuate electrical contact surface.
3. The vacuum deposition source of claim 1, wherein the heater comprises a layered structure comprising a pyrolytic graphite electrically resistive layer positioned between pyrolytic boron nitride electrically insulative layers.
4. The vacuum deposition source of claim 1, wherein the conductive washer comprises flexible graphite.
5. The vacuum deposition source of claim 1, wherein the pressure pin comprises a head portion and an alignment post portion and wherein the alignment post portion passes through an opening in the contact washer, an opening in the power strap, an opening in the conductive washer, and an opening in the heater.
6. The vacuum deposition source of claim 1, wherein the at least one loading pin comprises a cylindrical post comprising a flat surface that engages with an end of the pyrolytic boron nitride spring.
7. The vacuum deposition source of claim 1, wherein the pyrolytic boron nitride spring comprises a rectangular plate.
8. The vacuum deposition source of claim 1, wherein the electrical connection between the electrical power feed-through at the first end of the power strap comprises a flexible metal cable connected to the electrical power feed-through at a first end of the flexible metal cable and connected to the first end of the power strap at a second end of the flexible metal cable.
9. The vacuum deposition source of claim 1, wherein the heater comprising a plurality of cylindrically curving electrical contact surfaces.
10. A vacuum deposition source comprising:
a base flange configured to mount the vacuum deposition source to a vacuum chamber, the base flange comprising an electrical power feed-through;
a crucible operatively supported relative to the base flange and configured to hold vacuum deposition material, the crucible comprising a body portion and an effusion orifice;
a heater operatively supported relative to the base flange and at least partially surrounding the crucible, the heater comprising a cylindrical body portion configured and positioned to provide thermal radiation to at least a portion of the crucible, the heater comprising a layered structure comprising a cylindrical pyrolytic graphite electrically resistive layer positioned between cylindrical pyrolytic boron nitride electrically insulative layers and having an electrical contact comprising an exposed surface region of the graphite electrically resistive layer;
an electrical contact assembly comprising a power strap electrically connected to the electrical power feed-through at a first end of the power strap, electrically connected to the electrical contact of the heater at a second end of the power strap, and comprising a conductive washer in contact with the electrical contact, the power strap positioned between a contact washer and the conductive washer, a pressure pin in contact with the contact washer, a first surface of a pyrolytic boron nitride spring in contact with the pressure pin, and at least one loading pin in contact with a second surface of the pyrolytic boron nitride spring thereby providing a compressive load on the conductive washer.
11. The vacuum deposition source of claim 10, wherein the pyrolytic boron nitride spring comprises a rectangular plate.
12. The vacuum deposition source of claim 11, wherein the electrical contact assembly comprises a first loading pin in contact with a first end of the rectangular plate and a second loading pin spaced apart from the first loading pin and in contact with a second end of the rectangular plate.

1461117949-927d1d52-c626-4d15-9b5a-4de6d055be09

1. A vehicle comprising:
an internal combustion engine having a plurality of cylinders;
an exhaust gas purification catalyst which is arranged in an exhaust passage of the internal combustion engine and purifies exhaust gas;
a first air-fuel ratio detecting portion that is arranged upstream of the exhaust gas purification catalyst;
a second air-fuel ratio detecting portion that is arranged downstream of the exhaust gas purification catalyst; and
a control apparatus of the internal combustion engine,
wherein the control apparatus executes main feedback control that controls an air-fuel ratio of the internal combustion engine based on a detection value of the first air-fuel ratio detecting portion, and sub-feedback control that calculates a learning value for correcting the main feedback control based on a detection value of the second air-fuel ratio detecting portion; and
wherein the controlling apparatus includes a rotational variation calculating portion that calculates a rotational variation of an output shaft of the internal combustion engine based on combustion of each of the cylinders, a variation integrating portion that calculates a cumulative value of the rotational variation by adding the rotational variation calculated by the rotational variation calculating portion to the rotational variation integrated thus far, an integration counting portion that counts the number of times the rotational variation has been integrated by the variation integrating portion, a combustion state estimating portion that estimates a combustion state of the internal combustion engine according to the cumulative value of the rotational variation integrated by the variation integrating portion, on the condition that the number of integrations counted by the integration counting portion has reached a predetermined value; and a learning value correcting portion that corrects the learning value of the sub-feedback control according to the combustion state estimated by the combustion state estimating portion.
2. The vehicle according to claim 1,
wherein the control apparatus further includes a rotational position detecting portion that detects a rotational position of the output shaft of the internal combustion engine, and a required time calculating portion that calculates the required time that it takes for the output shaft to rotate a predetermined angle from the combustion stroke of the cylinders, based on the rotational position of the output shaft detected by the rotational position detecting portion, and
wherein the rotational variation calculating portion calculates the rotational variation of the output shaft based on a pre-obtained required time during a complete misfire, which is the time that it takes for the output shaft to rotate die predetermined angle when a complete misfire occurs in the cylinders during the combustion stroke, and a pre-obtained required time during complete combustion, which is the time that it takes for the output shaft to rotate the predetermined angle when complete combustion occurs in the cylinders during the combustion stroke, and the required time calculated by the required time calculating portion.
3. The vehicle according to claim 1, further comprising:
a combustion pressure detecting portion that detects a combustion pressure in the cylinders,
wherein the rotational variation calculating portion calculates the rotational variation of the output shaft by comparing the combustion pressure detected by the combustion pressure detecting portion with a pre-obtained combustion pressure during complete combustion.
4. The vehicle according to claim 1, further comprising:
an ion current detecting portion that detects ion current produced inside the cylinders during the combustion stroke,
wherein the rotational variation calculating portion calculates the rotational variation of the output shaft by comparing the ion current value detected by the ion current detecting portion with a pre-obtained ion current value during complete combustion.
5. The vehicle according to claim 1,
wherein the control apparatus further includes a disturbance detecting portion that detects a disturbance that contributes to variation in the combustion state of the internal combustion engine, and
wherein the variation integrating portion stops integrating the rotational variation when a disturbance that contributes to variation in the combustion state is detected by the disturbance detecting portion.
6. The vehicle according claim 5, wherein the disturbance detecting portion detects a load of the internal combustion engine being equal to or less than a predetermined value as a disturbance that contributes to variation in the combustion state.
7. The vehicle according to claim 5, wherein the disturbance detecting portion detects a coolant temperature of the internal combustion engine being equal to or less than a predetermined value as a disturbance that contributes to variation in the combustion state.
8. A control method of a vehicle that includes an internal combustion engine having a plurality of cylinders; an exhaust gas purification catalyst which is arranged in an exhaust passage of the internal combustion engine and purifies exhaust gas; a first air-fuel ratio detecting portion that is arranged upstream of the exhaust gas purification catalyst; a second air-fuel ratio detecting portion that is arranged downstream of the exhaust gas purification catalyst; and a control apparatus of the internal combustion engine, the control method comprising:
executing main feedback control that controls an air-fuel ratio of the internal combustion engine based on a detection value of the first air-fuel ratio detecting portion;
executing sub-feedback control that calculates a learning value for correcting the main feedback control based on a detection value of the second air-fuel ratio detecting portion;
calculating a rotational variation of an output shaft of the internal combustion engine based on combustion of each of the cylinders;
calculating a cumulative value of the rotational variation by adding the calculated rotational variation to the rotational variation integrated thus far;
counting the number of times the rotational variation has been integrated;
estimating a combustion state of the internal combustion engine according to the cumulative value of integrated rotational variation, on the condition that the number of counted integrations has reached a predetermined value; and
correcting the learning value of the sub-feedback control according to the estimated combustion state.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method of testing for one or more colorectal pathologies in a test subject, the method comprising:
(a) providing data representing a level of one or more products of each of at least two biomarkers in a sample isolated andor derived from said test subject, wherein said biomarkers are genes selected from the group consisting of BCNP1, CD163, CDA, MS4A1, BANK1, and MGC20553; and
(b) applying to said data a formula based on (i) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population having said one or more pathologies, and (ii) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population not having said one or more pathologies, thus providing an indication of a probability that said test subject has said one or more colorectal pathologies.
2. A computer-based method for testing for one or more colorectal pathologies in a test subject, the method comprising:
inputting, to a computer, data representing a level of products of each of at least two biomarkers in a sample isolated andor derived from a test subject, wherein said biomarkers are genes selected from the group consisting of BCNP1, CD163, CDA, MS4A1, BANK1 and MGC20553; and
causing said computer to apply to said data, a formula based on (i) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population having said one or more pathologies, and (ii) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population not having said one or more pathologies, thus providing an indication of a probability that said test subject has said one or more colorectal pathologies.
3. The method of claims 1 or 2, wherein said formula has a form:
V=C+\u03a3\u03b2iXi,

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, \u03b2i is a coefficient, and C is a constant.
4. The method of claims 1 or 2, wherein said formula has a form:
V=C+\u03a3\u03b2ij(XiXj),

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers; Xj is a level of products of a jth biomarker of said biomarkers where the ith biomarker is not the jth biomarker, \u03b2ij is a coefficient and C is a constant.
5. The method of claims 1 or 2, wherein said formula is derived by logistic regression.
6. The method of claims 1 or 2, wherein said sample is selected from the group consisting of blood, lymph and lymphoid tissue.
7. The method of claims 1 or 2 wherein said products in said sample are RNA.
8. The method of claims 1 or 2, wherein said sample is selected from the group consisting of a sample of serum-reduced blood, a sample of erythrocyte-reduced blood, a sample of serum-reduced and erythrocyte-reduced blood, a sample of unfractionated cells of lysed blood, and a sample of fractionated blood.
9. The method of claims 1 or 2, wherein said products in said sample are RNA, and whereas said data represents a level of cDNA, EST andor PCR product derived from said RNA.
10. A kit comprising packaging and containing at least two primer sets, wherein each set of which is able to generate an amplification product by selective amplification of at least a portion of a polynucleotide complementary to one or more RNA products of a biomarker, wherein said biomarker is a gene selected from the group consisting of: BCNP1, CD163, CDA, MS4A1, BANK1, and MGC20553; and wherein each set of said primer sets is selective for a different biomarker of said group.
11. The kit of claim 10, wherein said polynucleotide is selected from the group consisting of total RNA, mRNA, DNA, cDNA and EST.
12. The kit of claim 10, further comprising two or more oligonucleotide probes, wherein each of said probes is capable of selectively hybridizing to either a sense or an antisense strand of said amplification product.
13. The kit of claims 10, 11 or 12, further comprising two or more components selected from the group consisting of: a thermostable polymerase, a reverse transcriptase, deoxynucleotide triphosphates, nucleotide triphosphates and enzyme buffer.
14. The kit of claims 10, 11, 12 or 13, further comprising a computer-readable medium encoded with instructions for applying a formula to data representing levels of said amplification product in a sample isolated andor derived from a test subject, wherein said formula is said based on (i) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population having one or more colorectal pathologies, and (ii) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population not having said one or more pathologies, thus providing an indication of a probability that said test subject has said one or more colorectal pathologies.
15. The kit of claim 14, wherein said formula has a form:
V=C+\u03a3\u03b2iXi,

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, \u03b2i is a coefficient, and C is a constant.
16. The kit of claim 14, wherein said formula has a form:
V=C+\u03a3\u03b2ij(XiXj),

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, Xj is a level of products of a jth biomarker of said biomarkers where the ith biomarker is not the jth biomarker, \u03b2ij is a coefficient, and C is a constant.
17. The kit of claims 14, 15 or 16, wherein said sample is selected from the group consisting of blood, lymph and lymphoid tissue.
18. The kit of claims 14, 15 or 16, wherein said sample is selected from the group consisting of a sample of serum-reduced blood, a sample of erythrocyte-reduced blood, a sample of serum-reduced and erythrocyte-reduced blood, a sample of unfractionated cells of lysed blood and a sample of fractionated blood.
19. A computer-readable medium having instructions stored thereon that are operable when executed by a computer to apply a formula to data representing a level of one or more products of each of at least two biomarkers in a sample isolated andor derived from a test subject, wherein said biomarkers are genes selected from the group consisting of BCNP1, CD163, CDA, MS4A1, BANK1, and MGC20553, wherein said formula is based on (i) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population having one or more colorectal pathologies, and (ii) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population not having said one or more pathologies, thus providing an indication of a probability that said test subject has said one or more colorectal pathologies.
20. The computer-readable medium of claim 19, wherein said formula has a form:
V=C+\u03a3\u03b2iXi,

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, \u03b2i is a coefficient, and C is a constant.
21. The computer-readable medium of claim 19, wherein said formula has a form:
V=C+\u03a3\u03b2ij(XiXj),

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, and Xj is a level of products of a jth biomarker of said biomarkers, where the ith biomarker is not the jth biomarker, \u03b2ij is a coefficient and C is a constant.
22. The computer-readable medium of claim 19 wherein said formula is derived by logistic regression.
23. The computer-readable medium of claim 19 wherein said sample is selected from the group consisting of blood, lymph and lymphoid tissue.
24. The computer-readable medium of claims 19 wherein said products in said sample are RNA.
25. The computer-readable medium of claim 19, wherein said sample is selected from the group consisting of a sample of serum-reduced blood, a sample of erythrocyte-reduced blood, a sample of serum-reduced and erythrocyte-reduced blood, a sample of unfractionated cells of lysed blood, and a sample of fractionated blood.
26. The computer-readable medium of claim 19 wherein said products in said sample are RNA, and whereas said data represents a level of cDNA, EST andor PCR product derived from said RNA.
27. A computer system for providing an indication of a probability that a test subject has one or more colorectal pathologies, the computer system comprising
a processor; and
a memory configured with instructions that, when executed, cause said processor to provide a user with said indication, wherein said instructions comprise applying a formula to data representing a level of one or more products of each of at least two biomarkers in a sample isolated andor derived from said test subject, wherein said biomarkers are genes selected from the group consisting of BCNP1, CD163, CDA, MS4A1, BANK1, and MGC20553; and wherein said formula is based on (i) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population having said one or more pathologies, and (ii) a dataset representing levels of one or more products of each of said biomarkers in each subject of a reference population not having said one or more pathologies, thus providing said indication of said probability that said test subject has said one or more colorectal pathologies.
28. The system of claim 27, wherein said formula has a form:
V=C+\u03a3\u03b2iXi,

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, \u03b2i is a coefficient, and C is a constant.
29. The system of claim 27, wherein said formula has a form:
V=C+\u03a3\u03b2ij(XiXj),

wherein V is a value indicating a probability that said test subject has said one or more colorectal pathologies, Xi is a level of products of an ith biomarker of said biomarkers, and Xj is a level of products of a jth biomarker of said biomarkers, where the ith biomarker is not the jth biomarker, \u03b2ij is a coefficient, and C is a constant.
30. The system of claim 27, wherein said formula is derived by logistic regression.
31. The system of claim 27, wherein said sample is selected from the group consisting of blood, lymph and lymphoid tissue.
32. The system of claim 27, wherein said products in said sample are RNA.
33. The system of claim 27 wherein said sample is selected from the group consisting of a sample of serum-reduced blood, a sample of erythrocyte-reduced blood, a sample of serum-reduced and erythrocyte-reduced blood, a sample of unfractionated cells of lysed blood, and a sample of fractionated blood.
34. The system of claim 27 wherein said products in said sample are RNA, and whereas said data represents a level of cDNA, EST andor PCR product derived from said RNA.